![Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis | Neurodegenerative Disease Management Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis | Neurodegenerative Disease Management](https://www.futuremedicine.com/cms/10.2217/nmt.13.42/asset/images/medium/figure1.gif)
Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis | Neurodegenerative Disease Management
![From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis. - Abstract - Europe PMC From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5652031/bin/CN-15-874_F1.jpg)
From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis. - Abstract - Europe PMC
![Degenerative Neurological and Neuromuscular Disease Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis | Semantic Scholar Degenerative Neurological and Neuromuscular Disease Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9110afdf7a0e765957c9d6764fddf39c46c20571/4-Figure3-1.png)
Degenerative Neurological and Neuromuscular Disease Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis | Semantic Scholar
![Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre,... | Download Scientific Diagram Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre,... | Download Scientific Diagram](https://www.researchgate.net/profile/Jiwon-Oh-3/publication/237200436/figure/fig2/AS:203021809131532@1425415579831/Mechanism-of-action-of-teriflunomide-Note-Reprinted-from-Tallantyre-et-al-Int-MS-J_Q640.jpg)
Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre,... | Download Scientific Diagram
![Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre... | Download Scientific Diagram Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre... | Download Scientific Diagram](https://www.researchgate.net/publication/270134731/figure/fig3/AS:406690139787266@1473973893409/Mechanism-of-action-of-teriflunomide-Note-Reprinted-from-Tallantyre-et-al-Spotlight-on.png)
Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre... | Download Scientific Diagram
![Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre... | Download Scientific Diagram Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre... | Download Scientific Diagram](https://www.researchgate.net/publication/270134731/figure/fig1/AS:406690135592965@1473973892918/Molecular-and-cellular-changes-in-multiple-sclerosis-The-mechanisms-of-direct-neuronal_Q320.jpg)
Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre... | Download Scientific Diagram
![Merits and culprits of immunotherapies for neurological diseases in times of COVID-19 - EBioMedicine Merits and culprits of immunotherapies for neurological diseases in times of COVID-19 - EBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2bbec287-b3e4-4661-afc6-453794406513/gr1_lrg.jpg)
Merits and culprits of immunotherapies for neurological diseases in times of COVID-19 - EBioMedicine
![The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study | SpringerLink The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40268-019-00286-z/MediaObjects/40268_2019_286_Fig1_HTML.png)
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study | SpringerLink
![What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question - ScienceDirect What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661817300373-fx1.jpg)
What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question - ScienceDirect
![Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis: Molecular Therapy Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis: Molecular Therapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119340453/2092431181/fx1.jpg)
Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis: Molecular Therapy
![Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre,... | Download Scientific Diagram Mechanism of action of teriflunomide. Note: Reprinted from Tallantyre,... | Download Scientific Diagram](https://www.researchgate.net/profile/Jiwon-Oh-3/publication/237200436/figure/fig2/AS:203021809131532@1425415579831/Mechanism-of-action-of-teriflunomide-Note-Reprinted-from-Tallantyre-et-al-Int-MS-J.png)